Cargando…

Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells

BACKGROUND: Cannabidiol (CBD), the main non-psychoactive cannabinoid, has been previously shown by us to ameliorate clinical symptoms and to decrease inflammation in myelin oligodendrocyte glycoprotein (MOG)35-55-induced mouse experimental autoimmune encephalomyelitis model of multiple sclerosis as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kozela, Ewa, Juknat, Ana, Kaushansky, Nathali, Ben-Nun, Avraham, Coppola, Giovanni, Vogel, Zvi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363052/ https://www.ncbi.nlm.nih.gov/pubmed/25880134 http://dx.doi.org/10.1186/s12974-015-0273-0

Ejemplares similares

Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells
por: Kozela, Ewa, et al.
Publicado: (2016)

Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid
por: Kozela, Ewa, et al.
Publicado: (2017)

miRNA expression profiles and molecular networks in resting and LPS-activated BV-2 microglia—Effect of cannabinoids
por: Juknat, Ana, et al.
Publicado: (2019)

Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells
por: Juknat, Ana, et al.
Publicado: (2013)

DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele
por: Kaushansky, Nathali, et al.
Publicado: (2014)

The Median Eminence, A New Oligodendrogenic Niche in the Adult Mouse Brain
por: Zilkha-Falb, Rina, et al.
Publicado: (2020)

Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death
por: Rimmerman, N, et al.
Publicado: (2013)

Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?
por: Martínez, Vicente, et al.
Publicado: (2020)

Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease
por: Zilkha-Falb, Rina, et al.
Publicado: (2016)

DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP)
por: Kaushansky, Nathali, et al.
Publicado: (2012)

‘Multi-Epitope-Targeted’ Immune-Specific Therapy for a Multiple Sclerosis-Like Disease via Engineered Multi-Epitope Protein Is Superior to Peptides
por: Kaushansky, Nathali, et al.
Publicado: (2011)

Understanding Cannabinoid Psychoactivity with Mouse Genetic Models
por: Mackie, Ken
Publicado: (2007)

Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid
por: Merrick, John, et al.
Publicado: (2016)

Transcriptional regulator early growth response gene 2 (Egr2) is required for T cell anergy in vitro and in vivo
por: Zheng, Yan, et al.
Publicado: (2012)

Cannabidiol Regulates Gene Expression in Encephalitogenic T cells Using Histone Methylation and noncoding RNA during Experimental Autoimmune Encephalomyelitis
por: Yang, Xiaoming, et al.
Publicado: (2019)

N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor
por: McHugh, Douglas, et al.
Publicado: (2010)

Cannabidiol and Other Cannabinoids in Demyelinating Diseases
por: Navarrete, Carmen, et al.
Publicado: (2021)

Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect
por: Solinas, Marta, et al.
Publicado: (2013)

T(H) Cells and Cytokines in Encephalitogenic Disorders
por: Krishnarajah, Sinduya, et al.
Publicado: (2022)

In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
por: Gugliandolo, Agnese, et al.
Publicado: (2018)

Uncovering the psychoactivity of a cannabinoid from liverworts associated with a legal high
por: Chicca, A., et al.
Publicado: (2018)

Cellular immunity to encephalitogenic peptide in tumour-bearing mice.
por: Yong, W. K., et al.
Publicado: (1982)

Lymphocyte Anergy in Patients with Carcinoma
por: Nind, A. P. P., et al.
Publicado: (1973)

Identification of the synthetic cannabinoid‐type new psychoactive substance, CH‐PIACA, in seized material
por: Pasin, Daniel, et al.
Publicado: (2022)

Non-Psychoactive Cannabinoid Modulation of Nociception and Inflammation Associated with a Rat Model of Pulpitis
por: Laks, Elana Y., et al.
Publicado: (2023)

Cannabinoid non-cannabidiol site modulation of TRPV2 structure and function
por: Zhang, Liying, et al.
Publicado: (2022)

Encephalitogenicity of myelin basic protein exon-2 peptide in mice
por: Fritz, Robert B., et al.
Publicado: (1994)

Response: proliferative versus functional anergy
por: Charles, Edgar D., et al.
Publicado: (2011)

A Rare Case of Cannabinoid Hyperemesis Syndrome Secondary to Cannabidiol for Refractory Epilepsy
por: Katz, Daphna T., et al.
Publicado: (2023)

Effects of encephalitogenic factor on lymphocytic electrophoretic mobility for cancer patients and controls.
por: Chiu, B., et al.
Publicado: (1977)

T-bet is essential for encephalitogenicity of both Th1 and Th17 cells
por: Yang, Yuhong, et al.
Publicado: (2009)

TCR Affinity for Self-Ligands Influences the Development and Function of Encephalitogenic T Cells
por: Li, Jianwei, et al.
Publicado: (2011)

IL-3 Is a Marker of Encephalitogenic T Cells, but Not Essential for CNS Autoimmunity
por: Lee, Priscilla W., et al.
Publicado: (2018)

c-Met is expressed by highly autoreactive encephalitogenic CD8+ cells
por: Benkhoucha, Mahdia, et al.
Publicado: (2020)

GPR52 regulates cAMP in T cells but is dispensable for encephalitogenic responses
por: Krieg, Paula F., et al.
Publicado: (2023)

Transition-based reweighting and neural rational inference analysis of effects of new psychoactive substances on cannabinoid receptors
por: Dutta, Soumajit, et al.
Publicado: (2023)

α-Glucosidase inhibitory activity of cannabidiol, tetrahydrocannabinol and standardized cannabinoid extracts from Cannabissativa
por: Suttithumsatid, Wiwit, et al.
Publicado: (2022)

GRAIL: a gene related to anergy in lymphocytes
por: Fathman, G, et al.
Publicado: (2003)

A Case of Status Epilepticus and Transient Stress Cardiomyopathy Associated with Smoking the Synthetic Psychoactive Cannabinoid, UR-144
por: Fawaz, Sarah Al, et al.
Publicado: (2019)

CONTRIBUTIONS TO THE PATHOLOGY OF EXPERIMENTAL VIRUS ENCEPHALITIS : II. HERPETIC STRAINS OF ENCEPHALITOGENIC VIRUS.
por: Flexner, Simon, et al.
Publicado: (1925)

Cannot write session to /tmp/vufind_sessions/sess_vftn1gd4dufs1kh7r53kolj9v1